A biotech startup called Vivodyne is shaking up AI drug discovery by building robotic labs that grow and test real human tissue—solving the critical data gap that’s holding back AI’s medical potential. While current AI models rely on animal or single-cell data that doesn’t translate to humans, Vivodyne’s HIVE system generates accurate, living-tissue insights—with liver toxicity predictions at 94% and airway tissue matching at 96%. Raised nearly $80M and dubbed the world’s largest “human data center,” they’re partnering with pharma giants to accelerate drug development, turning biological experiments into reliable training data for next-gen AI. Their vision? To train AI on dynamic, cause-and-effect human biology—not static snapshots—to finally unlock breakthroughs for complex diseases.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
